(2,4-Di:oxy-6-methyl-pyrimidinyl-5-sulphonamino) di:phenyl-sulphone - used to treat skin rash caused by rheumatoid arthritis

The cpd. p.p-(2,4-dioxy-6-methyl-pyrimidinyl-5-sulphonamino)-diphenyl-sulp- hone is mixed with carrier. A tablet contains 0.1-0.2 gram of the cpd. The carrier is e.g. an injection solvent, distilled water or physiological salt soln. Used to cure red spot rash of human skin caused by rheumatoid arthr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: NIKOLAI MIKHAILOVICH GOLOSCHAPOV, YAKOV ALEXANDROVICH SIGIDIN, ELENA SERGEEVNA T
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The cpd. p.p-(2,4-dioxy-6-methyl-pyrimidinyl-5-sulphonamino)-diphenyl-sulp- hone is mixed with carrier. A tablet contains 0.1-0.2 gram of the cpd. The carrier is e.g. an injection solvent, distilled water or physiological salt soln. Used to cure red spot rash of human skin caused by rheumatoid arthritis. LA PRESENTE INVENTION CONCERNE UN NOUVEAU MEDICAMENT POUR LE TRAITEMENT DES COLLAGENOSES D'ETIOLOGIE RHUMATOIDE.CONFORMEMENT A L'INVENTION, LE MEDICAMENT POUR LE TRAITEMENT DES COLLAGENOSES D'ETIOLOGIE RHUMATOIDE CONTIENT COMME PRINCIPE ACTIF LA P,P-(2,4-DIOXO-6-METHYLPYRIMIDINYL-5-SULFONAMIDO) DIPHENYLSULFONE DE FORMULE SUIVANTE:(CF DESSIN DANS BOPI)EN ASSOCIATION AVEC UN SUPPORT PHARMACEUTIQUE APPROPRIE.LE MEDICAMENT EST UTILISABLE POUR LE TRAITEMENT DE DIVERSES FORMES DE COLLAGENOSES D'ETIOLOGIE RHUMATOIDE, TELLES QUE L'ARTHRITE RHUMATOIDE, LA SCLERODERMIE SYSTEMIQUE, LE LUPUS ERYTHEMATEUX SYSTEMIQUE.